Gerald Künstle

Dr. Gerald Künstle

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Plants
Verified
Journal Article
Open access
PDF file
JRJohann Röhrl
Johann Röhrl
MPMaria-Riera Piqué-Borràs
Maria-Riera Piqué-Borràs
MJManuela Jaklin
Manuela Jaklin
MWMarkus Werner
Markus Werner
OWOliver Werz
Oliver Werz
GKGerald Künstle
Gerald Künstle
Arnica montana is well known for its anti-inflammatory properties. While the anti-inflammatory activity of Arnica flowers (Arnicae flos) has been extensively studied, that of the whole plant (Arnicae planta tota) is less characterized. We compared the ability of Arnicae planta tota and Arnicae flos extracts to inhibit the pro-inflammatory NF-κB—eicosanoid pathway, using several in vitro and in vivo assays. We showed that Arnicae planta tota inhibited NF-κB reporter activation, with an IC50 of 15.4 μg/mL (vs. 52.5 μg/mL for Arnicae flos). Arnicae planta tota also inhibited LPS-induced expression of ALOX5 and PTGS2 genes in human differentiated macrophages. ALOX5 and PTGS2 encode the 5-lipoxygenase (5-LO) and cyclooxygenase-2 (COX-2) enzymes that initialize the conversion of arachidonic acid into leukotrienes and prostaglandins, respectively. Arnicae planta tota inhibited 5-LO and COX-2 enzymatic activity in vitro and in human primary peripheral blood cells, with lower IC50 compared to Arnicae flos. Finally, Arnicae planta tota applied topically reduced carrageenan-induced mouse paw oedema more efficiently than Arnicae flos. Altogether, Arnicae planta tota displayed a superior anti-inflammatory activity compared to Arnicae flos, suggesting that Arnicae-planta-tota-containing products might be more effective in alleviating the manifestations of acute inflammation than those based on Arnicae flos alone.

28 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JRJohann Röhrl
Johann Röhrl
MPMaria-Riera Piqué-Borràs
Maria-Riera Piqué-Borràs
MEMónica Mennet-Von Eiff
Mónica Mennet-Von Eiff
GKGerald Künstle
Gerald Künstle
Background/Objectives: Dry eye disease (DED) is a multifactorial condition affecting the ocular surface. It is characterized by tear film instability, hyperosmolarity, inflammation, and oxidative stress. First-line treatment for DED relies on lubricating and hydrating eye drops, usually containing hyaluronic acid (HA), which supports tear film stability and epithelial healing. However, HA alone cannot correct oxidative stress, a key driver of cellular damage and inflammation in DED. Accordingly, this study aimed to evaluate the antioxidant capacity of Malva sylvestris tincture (MalvaT) and its physicochemical properties in experimental eye-drop formulations containing HA. Methods: The antioxidant activity of reconstituted MalvaT lyophilisate (Malva) was assessed in cell-free assays against several oxygen radicals and in cell-based assays using the human HaCat keratinocyte cell line. The refractive index was measured in eye-drop formulations containing 0.15% or 0.3% HA and 0.5% MalvaT. Surface tension was assessed in eye-drop formulations containing 0.15% HA and increasing concentrations (0.25–2.0%) of MalvaT. Results: Malva showed potent oxygen radical scavenging activity in both cell-free and cell-based assays, indicating its antioxidant capacity and the efficient cellular uptake of antioxidant components. The refractive indices of experimental eye-drop solutions containing HA and MalvaT were close to that of tear fluid (1.334). The surface tension of the experimental eye-drop formulations, while not impacted by 0.15% HA, was significantly reduced by increasing concentrations of MalvaT (p < 0.0001). At the concentration of 0.5% MalvaT, the mean surface tension was reduced from 68.17 mN/m (HA control) to 59.80 mN/m (HA + MalvaT), thereby bringing it closer to that of tear fluid. Conclusions: This pre-clinical study suggests that combining the antioxidant properties of Malva tincture with the lubricating and hydrating effects of HA in eye-drop formulations exhibiting optimal rheological characteristics may offer a promising therapeutic approach for managing DED.

20 March 2026 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
PDF file
PRPhil Richter
Phil Richter
MPMaria-Riera Piqué-Borràs
Maria-Riera Piqué-Borràs
GKGerald Künstle
Gerald Künstle
VSVeronika Somoza
Veronika Somoza
The effects of herbal remedies aiding digestion are well known, but the underlying mechanisms remain poorly understood. Notably, many of these preparations are bitter, and bitter‐tasting phenolic food constituents have been shown to induce digestive processes by activating extra‐oral bitter taste receptors (TAS2Rs). This study examined the effects of a commercially available herbal mixture preparation used to aid digestive discomfort and nine solvent extracts thereof on proton secretion of immortalized human parietal cells (HGT‐1). The bitter taste of the preparation was sensorially evaluated, and its impact on the gene expression of the polyphenol‐related receptors TAS2R4 , TAS2R5 , and TAS2R39 was analyzed. Functional TAS2R involvement was validated using CRISPR‐Cas9 knock‐out and siRNA knock‐down approaches. Total polyphenol content was quantified using Folin‐Ciocalteu reagent. The bitter‐tasting herbal mixture preparation and several of its solvent extracts stimulated proton secretion by HGT‐1 cells concentration‐dependently. Four extracts exhibited high total polyphenol content and induced strong secretory responses, whereas five extracts showed lower content and weaker effects ( p < 0.01). Reduced responses were observed in TAS2R4ko, TAS2R5kd, and TAS2R39ko cells. In conclusion, bitter‐tasting plant extracts can stimulate TAS2R‐mediated digestive processes depending on their total polyphenol content, thereby supporting their use as promising remedies for alleviating digestive discomfort.